NEW YORK--(BUSINESS WIRE)--The Klein Law Firm announces the commencement of an investigation of Alkermes plc (NASDAQ: ALKS) concerning possible violations of federal securities laws.
On November 6, 2017, it was announced that an investigation has commenced concerning Alkermes’ sales practices for Vivitrol. In particular, Senator Kamala Harris said the Company had “aggressively marketed” Vivitrol and contributed to “misconceptions about other medications used in the fight to combat the opioid epidemic...”
If you suffered a loss in Alkermes and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kkclasslaw.com/ALKS-Info-Request-Form-229.
Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.